Clinical Trials

30 enrolled

Phase 2 Active not recruiting

Stomach Neoplasms

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

30 enrolled

Advanced Biliary Tract Carcinoma

NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

276 enrolled

Other neoplasm

Malignant Neoplasms of Digestive Organs

NCT07165847 2025-09-10

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

40 enrolled

Phase 2 Not yet recruiting

Stomach Neoplasms

NCT07007182 2025-09-05

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

54 enrolled

Stomach Neoplasms

NCT01720563 2025-06-04

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

17 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06988956 2025-05-25

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

95 enrolled

Esophageal Squamous Cell Carcinoma

NCT06427005 2025-01-22

Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC

66 enrolled

Fruquintinib

NCT06354140 2024-07-17

PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

45 enrolled

Phase 2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT06439550 2024-06-03

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

42 enrolled

Phase 2 Not yet recruiting

HER2-positive Gastric Cancer

NCT06383078 2024-04-25

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

120 enrolled

Efficacy and Safety

NCT06339619 2024-04-01

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

32 enrolled

Esophageal Squamous Cell Carcinoma

NCT06187597 2024-03-12

EC-CRT-007

140 enrolled

Esophageal Squamous Cell Carcinoma

NCT00004860 2023-06-15

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05594381 2022-10-26

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

90 enrolled

Stomach Neoplasms

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05070598 2021-10-07

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

35 enrolled

HER2-positive Gastric Cancer

NCT03154983 2020-12-09

The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer

48 enrolled

Stomach Neoplasms

NCT04571489 2020-10-01

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

60 enrolled

Pancreatic Neoplasms

NCT04216758 2020-06-30

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

300 enrolled

Stage IA Pancreatic Adenocarcinoma

NCT04202484 2019-12-17

Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma

20 enrolled

Stomach Neoplasms

NCT03121313 2019-02-12

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

68 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT02527785 2017-08-23

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

44 enrolled

Stomach Neoplasms

NCT03204019 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

60 enrolled

Adenoma, Islet Cell

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

EndocrineGastrointestinalNET

60 enrolled

Extrapancreatic Neuroendocrine Tumor

NCT02447679 2017-02-07

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

40 enrolled

Carcinoma, Hepatocellular, Drug-Related Side Effects and Adverse Reactions

NCT02943252 2016-10-24

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01050426 2016-10-14

PERU

17 enrolled

Pancreatic Neoplasms

NCT02903498 2016-10-12

The Maintenance Treatment of UFT in Advanced Gastric Cancer

58 enrolled

Stomach Neoplasms

NCT02623153 2015-12-07

Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

200 enrolled

Stomach Neoplasms

NCT01262274 2015-05-21

Neo-ACET BC

57 enrolled

Breast

Breast Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

110 enrolled

Rectal Neoplasms

NCT02090153 2014-03-18

Study of S-1 Plus LV for Advanced Gastric Cancer

39 enrolled

Stomach Neoplasms

NCT00005608 2012-06-06

Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

Breast

Breast Neoplasms

NCT00519688 2011-10-17

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

44 enrolled

Carcinoma, Hepatocellular

NCT00464919 2009-07-07

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

50 enrolled

Carcinoma, Hepatocellular

NCT00890188 2009-05-07

UFUR

34 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00384800 2009-02-09

A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

41 enrolled

Carcinoma, Hepatocellular

NCT00625352 2008-02-28

Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

48 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00037089 2005-06-24

A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer